Lv1
18 积分 2024-03-30 加入
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
1天前
待确认
Autologous CD7 CAR T cells generated without T-cell pre-selection in pediatric patients with relapsed/refractory T-ALL: a phase I trial
3天前
已完结
CD107a Degranulation Assay to Evaluate Immune Cell Antitumor Activity
3天前
已完结
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy
5天前
已完结
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies
6天前
已完结
Donor-derived and off-the-shelf allogeneic anti-CD19 CAR T-cell therapy for R/R ALL and NHL: A systematic review and meta-analysis
8天前
已完结
Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors
10天前
已完结
c-Jun overexpression in CAR T cells induces exhaustion resistance
18天前
已完结
Single-Chain Antigen-Binding Proteins
19天前
已完结
Promoter’s Choice Drive CAR-T Efficiency
25天前
已完结
皖公网安备34019202002308
